Nishit Modi
6Patents
3h-index
24Co-inventors
57Inventor score
Filing activity: Jun 6, 1994 → Nov 19, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5464815A | Inhibition of heparin-binding | Human Necessities | 52 | Expired |
| US5849689A | Method of extending the plasma half-life of deletion variants of hepatocyte growth factor | Human Necessities | 8 | Expired |
| US6395707B1 | Methods of treatment utilizing variants of vascular endothelial cell growth factor | Human Necessities | 7 | Expired |
| US5851989A | Method of extending the plasma half-life of vascular endothelial cell growth factor | Human Necessities | 3 | Expired |
| US11939361B2 | Compositions of peptide inhibitors of Interleukin-23 receptor | Human Necessities | 0 | Active |
| US8524749B2 | Controlled release compositions of tizanidine | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.